TAZOLINE Trademark

Trademark Overview


On Wednesday, November 8, 2000, a trademark application was filed for TAZOLINE with the United States Patent and Trademark Office. The USPTO has given the TAZOLINE trademark a serial number of 76161892. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, October 9, 2005. This trademark is owned by DuPont Pharmaceuticals Company. The TAZOLINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging
tazoline

General Information


Serial Number76161892
Word MarkTAZOLINE
Filing DateWednesday, November 8, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, October 9, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 16, 2002

Trademark Statements


Goods and ServicesPharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 17, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBRISTOL-MYERS SQUIBB PHARMA COMPANY
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19810

Party NameBRISTOL-MYERS SQUIBB PHARMA COMPANY
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10154

Party NameDuPont Pharmaceuticals Company
Party Type10 - Original Applicant
Legal Entity Type02 - Partnership
AddressWilmington, DE 19805

Trademark Events


Event DateEvent Description
Tuesday, December 13, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, December 13, 2005ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 21, 2005EXTENSION 5 GRANTED
Thursday, March 10, 2005EXTENSION 5 FILED
Thursday, March 10, 2005TEAS EXTENSION RECEIVED
Friday, September 10, 2004EXTENSION 4 GRANTED
Friday, September 10, 2004EXTENSION 4 FILED
Friday, September 10, 2004TEAS EXTENSION RECEIVED
Friday, July 30, 2004CASE FILE IN TICRS
Tuesday, March 23, 2004EXTENSION 3 GRANTED
Tuesday, March 16, 2004EXTENSION 3 FILED
Tuesday, March 16, 2004TEAS EXTENSION RECEIVED
Thursday, October 16, 2003EXTENSION 2 GRANTED
Wednesday, October 8, 2003EXTENSION 2 FILED
Wednesday, October 8, 2003TEAS EXTENSION RECEIVED
Thursday, November 7, 2002EXTENSION 1 GRANTED
Thursday, October 17, 2002EXTENSION 1 FILED
Thursday, October 17, 2002TEAS EXTENSION RECEIVED
Tuesday, October 8, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 24, 2002TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2002NOTICE OF PUBLICATION
Tuesday, April 23, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2001LETTER OF SUSPENSION MAILED
Wednesday, January 31, 2001ASSIGNED TO EXAMINER